PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial
The German Hodgkin Study Group's HD18 trial established the safety and efficacy of PET-guided eBEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone in escalated doses) for the treatment of advanced-stage Hodgkin lymphoma. However, because of a...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
25 May 2021
|
| In: |
The lancet. Haematology
Year: 2021, Jahrgang: 8, Heft: 6, Pages: e398-e409 |
| ISSN: | 2352-3026 |
| DOI: | 10.1016/S2352-3026(21)00101-0 |
| Online-Zugang: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1016/S2352-3026(21)00101-0 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S2352302621001010 
|
| Verfasserangaben: | Stefanie Kreissl, Helen Goergen, Ina Buehnen, Carsten Kobe, Alden Moccia, Richard Greil, Dennis A Eichenauer, Josée M Zijlstra, Jana Markova, Julia Meissner, Michaela Feuring-Buske, Martin Soekler, Hans-Joachim Beck, Wolfgang Willenbacher, Wolf-Dieter Ludwig, Thomas Pabst, Max S Topp, Felicitas Hitz, Martin Bentz, Ulrich Bernd Keller, Dagmar Kühnhardt, Helmut Ostermann, Bernd Hertenstein, Walter Aulitzky, Georg Maschmeyer, Tom Vieler, Hans Eich, Christian Baues, Harald Stein, Michael Fuchs, Volker Diehl, Markus Dietlein, Andreas Engert, Peter Borchmann |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1816649120 | ||
| 003 | DE-627 | ||
| 005 | 20230118162302.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220914s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S2352-3026(21)00101-0 |2 doi | |
| 035 | |a (DE-627)1816649120 | ||
| 035 | |a (DE-599)KXP1816649120 | ||
| 035 | |a (OCoLC)1361714382 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kreissl, Stefanie |e VerfasserIn |0 (DE-588)1193064643 |0 (DE-627)1671605713 |4 aut | |
| 245 | 1 | 0 | |a PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18) |b follow-up analysis of an international, open-label, randomised, phase 3 trial |c Stefanie Kreissl, Helen Goergen, Ina Buehnen, Carsten Kobe, Alden Moccia, Richard Greil, Dennis A Eichenauer, Josée M Zijlstra, Jana Markova, Julia Meissner, Michaela Feuring-Buske, Martin Soekler, Hans-Joachim Beck, Wolfgang Willenbacher, Wolf-Dieter Ludwig, Thomas Pabst, Max S Topp, Felicitas Hitz, Martin Bentz, Ulrich Bernd Keller, Dagmar Kühnhardt, Helmut Ostermann, Bernd Hertenstein, Walter Aulitzky, Georg Maschmeyer, Tom Vieler, Hans Eich, Christian Baues, Harald Stein, Michael Fuchs, Volker Diehl, Markus Dietlein, Andreas Engert, Peter Borchmann |
| 264 | 1 | |c 25 May 2021 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 14.09.2022 | ||
| 520 | |a The German Hodgkin Study Group's HD18 trial established the safety and efficacy of PET-guided eBEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone in escalated doses) for the treatment of advanced-stage Hodgkin lymphoma. However, because of a protocol amendment during the enrolment period (June 1, 2011) that changed standard treatment from eight to six cycles, the results of the HD18 trial have been partially immature. We report a prespecified 5-year follow-up analysis of the completed HD18 trial. | ||
| 700 | 1 | |a Goergen, Helen |e VerfasserIn |4 aut | |
| 700 | 1 | |a Buehnen, Ina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kobe, Carsten |e VerfasserIn |4 aut | |
| 700 | 1 | |a Moccia, Alden |e VerfasserIn |4 aut | |
| 700 | 1 | |a Greil, Richard |e VerfasserIn |4 aut | |
| 700 | 1 | |a Eichenauer, Dennis A |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zijlstra, Josée M |e VerfasserIn |4 aut | |
| 700 | 1 | |a Markova, Jana |e VerfasserIn |4 aut | |
| 700 | 1 | |a Meißner, Julia |e VerfasserIn |0 (DE-588)1236765966 |0 (DE-627)176254850X |4 aut | |
| 700 | 1 | |a Feuring-Buske, Michaela |e VerfasserIn |4 aut | |
| 700 | 1 | |a Soekler, Martin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Beck, Hans-Joachim |e VerfasserIn |4 aut | |
| 700 | 1 | |a Willenbacher, Wolfgang |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ludwig, Wolf-Dieter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pabst, Thomas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Topp, Max S |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hitz, Felicitas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bentz, Martin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Keller, Ulrich Bernd |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kühnhardt, Dagmar |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ostermann, Helmut |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hertenstein, Bernd |e VerfasserIn |4 aut | |
| 700 | 1 | |a Aulitzky, Walter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Maschmeyer, Georg |e VerfasserIn |4 aut | |
| 700 | 1 | |a Vieler, Tom |e VerfasserIn |4 aut | |
| 700 | 1 | |a Eich, Hans |e VerfasserIn |4 aut | |
| 700 | 1 | |a Baues, Christian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stein, Harald |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fuchs, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Diehl, Volker |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dietlein, Markus |e VerfasserIn |4 aut | |
| 700 | 1 | |a Engert, Andreas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Borchmann, Peter |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The lancet. Haematology |d London [u.a.] : Elsevier, 2014 |g 8(2021), 6, Seite e398-e409 |h Online-Ressource |w (DE-627)810540304 |w (DE-600)2802056-X |w (DE-576)420435689 |x 2352-3026 |7 nnas |a PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18) follow-up analysis of an international, open-label, randomised, phase 3 trial |
| 773 | 1 | 8 | |g volume:8 |g year:2021 |g number:6 |g pages:e398-e409 |g extent:12 |a PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18) follow-up analysis of an international, open-label, randomised, phase 3 trial |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S2352-3026(21)00101-0 |x Resolving-System |x Verlag |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S2352302621001010 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220914 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 1236765966 |a Meißner, Julia |m 1236765966:Meißner, Julia |d 910000 |d 910100 |e 910000PM1236765966 |e 910100PM1236765966 |k 0/910000/ |k 1/910000/910100/ |p 10 | ||
| 999 | |a KXP-PPN1816649120 |e 4188149558 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1816649120","title":[{"title_sort":"PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18)","title":"PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18)","subtitle":"follow-up analysis of an international, open-label, randomised, phase 3 trial"}],"id":{"eki":["1816649120"],"doi":["10.1016/S2352-3026(21)00101-0"]},"note":["Gesehen am 14.09.2022"],"person":[{"given":"Stefanie","role":"aut","display":"Kreissl, Stefanie","family":"Kreissl","roleDisplay":"VerfasserIn"},{"given":"Helen","role":"aut","display":"Goergen, Helen","family":"Goergen","roleDisplay":"VerfasserIn"},{"family":"Buehnen","roleDisplay":"VerfasserIn","display":"Buehnen, Ina","role":"aut","given":"Ina"},{"roleDisplay":"VerfasserIn","family":"Kobe","given":"Carsten","display":"Kobe, Carsten","role":"aut"},{"given":"Alden","role":"aut","display":"Moccia, Alden","family":"Moccia","roleDisplay":"VerfasserIn"},{"family":"Greil","roleDisplay":"VerfasserIn","given":"Richard","role":"aut","display":"Greil, Richard"},{"family":"Eichenauer","roleDisplay":"VerfasserIn","display":"Eichenauer, Dennis A","role":"aut","given":"Dennis A"},{"display":"Zijlstra, Josée M","role":"aut","given":"Josée M","roleDisplay":"VerfasserIn","family":"Zijlstra"},{"display":"Markova, Jana","role":"aut","given":"Jana","roleDisplay":"VerfasserIn","family":"Markova"},{"roleDisplay":"VerfasserIn","family":"Meißner","given":"Julia","role":"aut","display":"Meißner, Julia"},{"role":"aut","display":"Feuring-Buske, Michaela","given":"Michaela","family":"Feuring-Buske","roleDisplay":"VerfasserIn"},{"family":"Soekler","roleDisplay":"VerfasserIn","given":"Martin","display":"Soekler, Martin","role":"aut"},{"roleDisplay":"VerfasserIn","family":"Beck","display":"Beck, Hans-Joachim","role":"aut","given":"Hans-Joachim"},{"roleDisplay":"VerfasserIn","family":"Willenbacher","given":"Wolfgang","role":"aut","display":"Willenbacher, Wolfgang"},{"roleDisplay":"VerfasserIn","family":"Ludwig","role":"aut","display":"Ludwig, Wolf-Dieter","given":"Wolf-Dieter"},{"given":"Thomas","display":"Pabst, Thomas","role":"aut","family":"Pabst","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Topp, Max S","given":"Max S","family":"Topp","roleDisplay":"VerfasserIn"},{"given":"Felicitas","display":"Hitz, Felicitas","role":"aut","roleDisplay":"VerfasserIn","family":"Hitz"},{"role":"aut","display":"Bentz, Martin","given":"Martin","family":"Bentz","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Keller, Ulrich Bernd","given":"Ulrich Bernd","family":"Keller","roleDisplay":"VerfasserIn"},{"given":"Dagmar","display":"Kühnhardt, Dagmar","role":"aut","family":"Kühnhardt","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Ostermann","display":"Ostermann, Helmut","role":"aut","given":"Helmut"},{"given":"Bernd","display":"Hertenstein, Bernd","role":"aut","family":"Hertenstein","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Aulitzky, Walter","given":"Walter","roleDisplay":"VerfasserIn","family":"Aulitzky"},{"family":"Maschmeyer","roleDisplay":"VerfasserIn","display":"Maschmeyer, Georg","role":"aut","given":"Georg"},{"roleDisplay":"VerfasserIn","family":"Vieler","display":"Vieler, Tom","role":"aut","given":"Tom"},{"given":"Hans","display":"Eich, Hans","role":"aut","roleDisplay":"VerfasserIn","family":"Eich"},{"role":"aut","display":"Baues, Christian","given":"Christian","roleDisplay":"VerfasserIn","family":"Baues"},{"display":"Stein, Harald","role":"aut","given":"Harald","family":"Stein","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Fuchs","given":"Michael","role":"aut","display":"Fuchs, Michael"},{"roleDisplay":"VerfasserIn","family":"Diehl","role":"aut","display":"Diehl, Volker","given":"Volker"},{"roleDisplay":"VerfasserIn","family":"Dietlein","role":"aut","display":"Dietlein, Markus","given":"Markus"},{"given":"Andreas","role":"aut","display":"Engert, Andreas","family":"Engert","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Borchmann, Peter","given":"Peter","family":"Borchmann","roleDisplay":"VerfasserIn"}],"physDesc":[{"extent":"12 S."}],"name":{"displayForm":["Stefanie Kreissl, Helen Goergen, Ina Buehnen, Carsten Kobe, Alden Moccia, Richard Greil, Dennis A Eichenauer, Josée M Zijlstra, Jana Markova, Julia Meissner, Michaela Feuring-Buske, Martin Soekler, Hans-Joachim Beck, Wolfgang Willenbacher, Wolf-Dieter Ludwig, Thomas Pabst, Max S Topp, Felicitas Hitz, Martin Bentz, Ulrich Bernd Keller, Dagmar Kühnhardt, Helmut Ostermann, Bernd Hertenstein, Walter Aulitzky, Georg Maschmeyer, Tom Vieler, Hans Eich, Christian Baues, Harald Stein, Michael Fuchs, Volker Diehl, Markus Dietlein, Andreas Engert, Peter Borchmann"]},"relHost":[{"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"dateIssuedDisp":"2014-","publisherPlace":"London [u.a.]","dateIssuedKey":"2014","publisher":"Elsevier"}],"part":{"text":"8(2021), 6, Seite e398-e409","volume":"8","issue":"6","extent":"12","year":"2021","pages":"e398-e409"},"physDesc":[{"extent":"Online-Ressource"}],"disp":"PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18) follow-up analysis of an international, open-label, randomised, phase 3 trialThe lancet. Haematology","note":["Gesehen am 27.11.14"],"title":[{"title":"The lancet","title_sort":"lancet","partname":"Haematology"}],"id":{"issn":["2352-3026"],"eki":["810540304"],"zdb":["2802056-X"]},"recId":"810540304","pubHistory":["1.2014 -"],"titleAlt":[{"title":"The lancet <London> / Haematology"}]}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"25 May 2021","dateIssuedKey":"2021"}],"language":["eng"]} | ||
| SRT | |a KREISSLSTEPETGUIDEDE2520 | ||